Benson is a senior associate of the Capital Markets practice and his practice focuses on corporate and commercial work. He regularly advises on matters in relation to listings and public offerings, mergers and acquisitions, regulatory compliance for listed companies, and general corporate and commercial matters.

Benson has experience in the following transactions with substantial involvement:
• Advising Kinetix Systems Holdings Limited (Stock Code: 8606) in relation to its rights issue in 2022
• Acting for Endurance RP Limited (Stock Code: 575) in relation to its rights issue in 2022 involving whitewash waiver, connected transaction and compensatory placing arrangement
• Advising Dongfeng Motor Group Company Limited (Stock Code: 489) in relation to its on-market H share repurchase in 2022
• Advising Shandong Gold Mining Company Limited (Stock Code: 1787) regarding the privatization of Hengxing Gold Holding Company Limited (Stock Code: 2303) by way of scheme of arrangement in 2020 (Public takeover)
• Advising Icon Culture Global Company Limited (Stock Code: 8500) as the issuer counsel on its IPO in 2020
• Acting for an American infant and toddler toy and product manufacturer on the Hong Kong law aspects in the re-financing of several cross-jurisdictional revolving facilities of up to US$108,000,000 as Hong Kong borrower counsel in 2020
• Acting for leading global manufacturer and supplier of high-quality application specific standard products on the Hong Kong law aspects of several cross-jurisdictional facility agreements of up to US$690,000,000 as Hong Kong borrower counsel in 2020
• Acting for an independent global automotive supplier of innovative and energy efficient powertrains on the Hong Kong law aspects of a cross-jurisdictional facility agreement of EUR350,000,000 as Hong Kong borrower counsel in 2020
• Advising Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) on its issuance of capitalization shares as Company legal counsel in 2018 and 2020
• Advising China Tianrui Automotive Interiors Co., Ltd (Stock Code: 6162) as the issuer counsel on its IPO in 2019
• Advising CGN Mining Company Limited (Stock Code: 1164) regarding a very substantial acquisition of a UK uranium trading company in 2018
• Advising Huakang Biomedical Holdings Company Limited (Stock Code: 8622) as the issuer counsel on its IPO in 2018
• Advising China Everbright as the sole sponsor and underwriter counsel on the IPO of China Shun Ke Long Holdings Limited (Stock Code: 974) in 2015
• Advising Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) as the issuer counsel on its IPO in 2015